ranimustine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, S; Ogawa, M | 1 |
| Ezaki, M; Furue, H; Fuse, K; Hirota, F; Kaise, R; Kako, M; Mugitani, H; Sakamoto, K; Suminaga, M; Takahashi, T; Yamada, K | 1 |
2 other study(ies) available for ranimustine and Breast Cancer
| Article | Year |
|---|---|
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin | 1982 |
[Phase II clinical trial of MCNU].
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Child, Preschool; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Parotid Neoplasms; Uterine Neoplasms | 1983 |